Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM LIVE

Healthcare & Pharma • • ISIN: N/A

₹4,875.00

▲ +-90.50 (+1.30%)

Data updated: Just now (NSE India Live Feed)

52W Low: ₹3,480.60

Today High / Low: ₹4,899.00 / ₹4,794.50

52W High: ₹5,250.00

Volume: 411,405

⚖️ Compare vs Peers

🎯 TickerPulse Confluence Engine Institutional 360°

360° Quantitative Confluence Radar DEFENSIVE QUALITY COMPOUNDER

Robust balance sheet and strong institutional sponsorship. Favorable for swing accumulation with standard 1% risk discipline.

Confluence Score

Moderate Edge

Valuation & Multiples 45/100

P/E, P/B, FCF yield vs historical levels

Trend & Moving Averages 96/100

20/50 EMA structure, RSI momentum, 52W range

Institutional Sponsorship 85/100

FII & DII holdings, delivery turnover backing

Balance Sheet Solvency 74/100

Debt-to-equity ratio, Altman Z score, operating margin

Asymmetric Reward-to-Risk 60/100

Calculated 1.68:1 potential target vs swing low stop

📐 Institutional Trade Setup 1% Risk Aligned

Entry Reference

₹4,875.00

Structural Stop Loss

₹4,584.94

Max Risk: -5.95%

Technical Target 1

₹5,362.50

Payoff Profile

1.68 : 1.0

Reward-to-Risk

🎯 Size This Trade (1% Risk Lab) → 🎮 Paper Trade Virtual Setup →

Transparent Business & Valuation Scoring

Methodology v1.0 • Every metric is deterministic and verifiable.

How we calculate scores →

Overall Quality Score

63 / 100

Moderate

Financial Health

72 / 100

Strong

Profitability & Margins

79 / 100

Strong

Growth Trajectory

40 / 100

Subdued

Valuation Attractiveness

46 / 100

Subdued

Interactive Price Performance & Trend

Live exchange closing feeds from NSE/BSE

50-Day DMA: ₹4,704.38

200-Day DMA: ₹4,363.13

14-Day RSI: 56.6 (Neutral)

Trend: Strong Bullish

Key Fundamentals & Ratios (Data as of 2026-08-30)

Market Cap ₹11,600,000.00L Cr Large_cap Category

P/E Ratio (TTM) 68.5x Sector Mean: ~28.5x

Price to Book (P/B) — Book Val: ₹0.0

Return on Equity (ROE) 26.5% Net Profit / Net Worth

ROCE — Capital Efficiency

Debt / Equity 0.65 Manageable Leverage

EPS (TTM) ₹0.00 Earnings Per Share

Dividend Yield 0.85% Annual Cash Payout

Operating Margin — Core Operational Spread

Annual Free Cash Flow ₹0.00 Cr Operating CF minus Capex

Algorithmic Analysis (Pros & Cons)

⚡ Computed from Balance Sheet & Valuation Metrics

✓

Company Strengths (Pros)

• Company has a stellar track record of return on equity (ROE of 26.5%).

⚠

Key Limitations & Risks (Cons)

• Commanding an elevated valuation multiple with P/E at 68.5x.

Fundamental Health

Piotroski F-Score

5 / 9

Balance Sheet Score: Stable Financials

Positive Return on Equity (ROE) ✓ PASS

High Capital Efficiency (ROCE > 12%) ✗ FAIL

Strong Operating Spread (Margin > 15%) ✗ FAIL

Positive Free Cash Flow Generation ✓ PASS

9-Point Stanford University fundamental screening model.

Solvency & Credit Risk

Altman Z-Score

3.8

Solvency Classification: Safe Zone (Low Distress)

Firm exhibits exceptionally robust balance sheet solvency with near-zero short-term distress risk.

Safe Zone (>2.99) • Grey Zone (1.81–2.99) • Distress (<1.81)

Valuation Model

Intrinsic Fair Value

DCF + Graham

Estimated Fair Value

₹1,269.86

Premium / Overvalued (-74%)

Graham Value

₹1,493.44

DCF Model

₹1,086.93

DuPont ROE: 14.4% NPM × 0.85 Turn × 1.65x Lev

Quarterly Financial Performance (Consolidated ₹ Cr)

Past 4 Reported Quarters

Metric (₹ Cr)	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales / Revenue	₹12,136.50 Cr	₹12,658.50 Cr	₹13,311.00 Cr	₹13,833.00 Cr
Operating Profit	₹2,172.43 Cr	₹2,316.51 Cr	₹2,489.16 Cr	₹2,642.10 Cr
OPM % (Operating Margin)	17.9%	18.3%	18.7%	19.1%
Profit before Tax (PBT)	₹1,737.95 Cr	₹1,853.20 Cr	₹1,991.33 Cr	₹2,113.68 Cr
Net Profit (PAT)	₹1,303.46 Cr	₹1,389.90 Cr	₹1,493.49 Cr	₹1,585.26 Cr
Quarterly EPS (₹)	₹16.55	₹17.26	₹18.15	₹18.86

Shareholding Pattern & Institutional Ownership

Latest Disclosed Quarter

Promoters

52.40%

Foreign Institutions (FIIs)

19.80%

Domestic Institutions (DIIs)

15.60%

Retail & Public

12.20%

Technical Levels & Intraday Pivot Matrix

Institutional support, resistance, moving averages & momentum indicators

⚡ Signal: Strong Bullish RSI (14): 56.6

📈 Key Moving Averages

20 EMA (Short Term)

₹4,816.50

50 SMA (Medium Term)

₹4,704.38

100 SMA (Structural)

₹4,572.75

200 SMA (Long Trend)

₹4,363.13

🎯 52-Week Range Alignment

Distance from 52W High (₹5,250.00) -7.1%

Distance from 52W Low (₹3,480.60) +40.1%

Pivot Model	Support 3	Support 2	Support 1	Central Pivot (P)	Resistance 1	Resistance 2	Resistance 3
Classic Floor	₹4,708.84	₹4,751.67	₹4,813.34	₹4,856.17	₹4,917.84	₹4,960.67	₹5,022.34
Camarilla Intraday	—	L4: ₹4,817.53	L3: ₹4,846.26	₹4,875.00	H3: ₹4,903.74	H4: ₹4,932.48	—
Fibonacci	—	61.8%: ₹4,810.42	38.2%: ₹4,835.08	₹4,856.17	38.2%: ₹4,914.92	61.8%: ₹4,939.58	—

Sector Peers Comparison (Healthcare & Pharma)

Peer Company	Price	Today Change	Market Cap	P/E Ratio	ROE (%)	Compare
NEULANDLAB — NEULAND LAB Ltd.	₹22,665.00	▲ +0.00 (+0.18%)	₹115,050,000.00L Cr	28.5x	16.4%	Compare →
SUNPHARMA — Sun Pharmaceutical Industries Ltd	₹1,867.30	▲ +0.00 (+0.75%)	₹45,100,000.00L Cr	38.4x	17.8%	Compare →
ASTRAZEN — ASTRAZENECA PHARMA IND LT	₹6,669.00	▼ 0.00 (-0.51%)	₹34,757,500.00L Cr	28.5x	16.4%	Compare →
AJANTPHARM — AJANTA PHARMA Ltd	₹3,500.50	▼ 0.00 (-0.24%)	₹18,009,500.00L Cr	28.5x	16.4%	Compare →
GLAXO — GLAXOSMITHKLINE PHARMA LT	₹2,799.90	▼ 0.00 (-1.97%)	₹15,250,500.00L Cr	28.5x	16.4%	Compare →

Save to Your Watchlist